ArticleMedical science monitor : international medical journal of experimental and clinical research2022
Retracted: The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib.
Hao Song et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.